Tag: chronic rhinosinusitis

FDA refuses to approve AstraZeneca’s sBLA for Fasenra in CRSwNP

pallavi123- March 19, 2022

The US Food and Drug Administration (FDA) has refused to approve the supplemental biologics license application (sBLA) of AstraZeneca’s asthma drug Fasenra (benralizumab) for the ... Read More

Medtronic to acquire ENT medical technology company Intersect ENT

businessnewstoday- August 6, 2021

Irish medical device company Medtronic has agreed to acquire Intersect ENT, an ear, nose, and throat (ENT) medical technology company, in an all-cash deal worth ... Read More

Lyra Therapeutics raises $30m for chronic rhinosinusitis drug candidates

pharmanewsdaily- February 1, 2020

Lyra Therapeutics has raised $30 million in a Series C financing round to advance its lead product candidates for the treatment of chronic rhinosinusitis (CRS). ... Read More